Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 584.52K CAD in the quarter ending May 31, 2026, a decrease of -25.32%. This brings the company's total for the last twelve months to 2.58M, up 4.30% year-over-year. In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M with 33.00% growth. That makes Rapid Dose Therapeutics the 42,549th largest company in the world by revenue and 846th in Canada.

• Revenue (ttm): 2.58M
• Revenue Growth: +4.30%
• P/S Ratio: 5.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 14.47M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2026	2.77M	688.14K	33.00%
Feb 28, 2025	2.09M	1.06M	104.34%
Feb 29, 2024	1.02M	302.13K	42.06%
Feb 28, 2023	718.30K	-1.03M	-59.00%
Feb 28, 2022	1.75M	996.72K	131.98%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error